SCHEMBL7340919

SCHEMBL7340919

COCCOCCOc1ccc2c(c1)S(=O)(=O)N(CSc1nnnn1-c1ccccc1)C2=O

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ELANE P08246 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304821 0.83 HPGD (0.43) ELANE
SCHEMBL7310549 0.79 ELANE (1.00) ELANE
SCHEMBL7309509 0.76 CA12 (0.53) ELANE
SCHEMBL7416544 0.76 ELANE (1.00) ELANE
SCHEMBL7301751 0.75 ELANE (0.80) ELANE
SCHEMBL7304844 0.74 ELANE (0.47) ELANE
SCHEMBL7307414 0.73 ELANE (1.00) ELANE
SCHEMBL7304289 0.72 ELANE (0.70) ELANE
SCHEMBL7412128 0.72 ELANE (0.80) ELANE
SCHEMBL7419633 0.72 ELANE (1.00) ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874432-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof SANOFI (FR) 1999-02-23 US disclosed
US-5650422-A TREATMENT OF EMPHYSEMA, ARTHRITIS OR PANCREATITIS SANOFI (FR) 1997-07-22 US disclosed
US-5596012-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1997-01-21 US disclosed
US-5371074-A Use of saccharin derivatives as proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-12-06 US disclosed
US-5236917-A Respiratory system disorders, antiarthritic agents STERLING WINTHROP INC. (US) 1993-08-17 US disclosed
EP-0542372-A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed